Design of a Multiepitope Pan-Proteomic mRNA Vaccine Construct Against African Swine Fever Virus: A Reverse Vaccinology Approach

African swine fever (ASF), caused by African swine fever virus (ASFV), is a highly contagious disease with devastating effects on the global pig industry. This warrants the development of effective control strategies, such as vaccines. However, previously developed inactivated vaccines have proven i...

Full description

Saved in:
Bibliographic Details
Main Authors: Ella Mae Joy S. Sira, Lauren Emily Fajardo, Edward C. Banico, Nyzar Mabeth O. Odchimar, Fredmoore L. Orosco
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Veterinary Medicine International
Online Access:http://dx.doi.org/10.1155/vmi/2638167
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841545633332199424
author Ella Mae Joy S. Sira
Lauren Emily Fajardo
Edward C. Banico
Nyzar Mabeth O. Odchimar
Fredmoore L. Orosco
author_facet Ella Mae Joy S. Sira
Lauren Emily Fajardo
Edward C. Banico
Nyzar Mabeth O. Odchimar
Fredmoore L. Orosco
author_sort Ella Mae Joy S. Sira
collection DOAJ
description African swine fever (ASF), caused by African swine fever virus (ASFV), is a highly contagious disease with devastating effects on the global pig industry. This warrants the development of effective control strategies, such as vaccines. However, previously developed inactivated vaccines have proven ineffective, while live-attenuated vaccines carry inherent safety risks. The use of mRNA vaccines eliminates these risks offering a safe, cost-effective, and efficient vaccine strategy against ASFV. In this study, a reverse vaccinology approach was used to design a multiepitope pan-proteomic mRNA vaccine against ASFV. Various bioinformatics tools were employed to predict epitopes for cytotoxic T lymphocytes, helper T lymphocytes, and B lymphocytes. A 50S ribosomal L7/L12 protein adjuvant, 5′ cap, poly(A) tail, signal peptide, and MHC-I-targeting domain were incorporated into the design using appropriate linkers to increase immunogenicity, stability, and recognition efficiency. The physicochemical properties of the final construct were evaluated, and docking analyses were done with Toll-like receptors (TLRs) 3, 4, and 7 to evaluate binding affinity. A molecular dynamics simulation was then performed to determine binding stability, while immune simulations evaluated host’s immune response. Based on 100 ASFV proteomes, six epitopes that induce cytotoxic T-cell responses, five epitopes that induce helper T-cell responses, and four epitopes that induce antibody production were predicted. The designed vaccine construct was found to be nonallergenic, antigenic, and stable when bound to TLR4 while the binding pocket analyses of the vaccine construct to TLR3 and TLR7 indicate high translation efficiency. Immune simulations demonstrated successful induction of immune responses and generation of antigen-specific memory cells. In conclusion, this study introduces an mRNA vaccine construct as a potential disease control strategy against ASF for in vitro confirmation.
format Article
id doaj-art-1014a90fb31345cbbd13fb8dad74e9d3
institution Kabale University
issn 2042-0048
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Veterinary Medicine International
spelling doaj-art-1014a90fb31345cbbd13fb8dad74e9d32025-01-12T00:00:01ZengWileyVeterinary Medicine International2042-00482025-01-01202510.1155/vmi/2638167Design of a Multiepitope Pan-Proteomic mRNA Vaccine Construct Against African Swine Fever Virus: A Reverse Vaccinology ApproachElla Mae Joy S. Sira0Lauren Emily Fajardo1Edward C. Banico2Nyzar Mabeth O. Odchimar3Fredmoore L. Orosco4Department of Science and TechnologyDepartment of Science and TechnologyDepartment of Science and TechnologyDepartment of Science and TechnologyDepartment of Science and TechnologyAfrican swine fever (ASF), caused by African swine fever virus (ASFV), is a highly contagious disease with devastating effects on the global pig industry. This warrants the development of effective control strategies, such as vaccines. However, previously developed inactivated vaccines have proven ineffective, while live-attenuated vaccines carry inherent safety risks. The use of mRNA vaccines eliminates these risks offering a safe, cost-effective, and efficient vaccine strategy against ASFV. In this study, a reverse vaccinology approach was used to design a multiepitope pan-proteomic mRNA vaccine against ASFV. Various bioinformatics tools were employed to predict epitopes for cytotoxic T lymphocytes, helper T lymphocytes, and B lymphocytes. A 50S ribosomal L7/L12 protein adjuvant, 5′ cap, poly(A) tail, signal peptide, and MHC-I-targeting domain were incorporated into the design using appropriate linkers to increase immunogenicity, stability, and recognition efficiency. The physicochemical properties of the final construct were evaluated, and docking analyses were done with Toll-like receptors (TLRs) 3, 4, and 7 to evaluate binding affinity. A molecular dynamics simulation was then performed to determine binding stability, while immune simulations evaluated host’s immune response. Based on 100 ASFV proteomes, six epitopes that induce cytotoxic T-cell responses, five epitopes that induce helper T-cell responses, and four epitopes that induce antibody production were predicted. The designed vaccine construct was found to be nonallergenic, antigenic, and stable when bound to TLR4 while the binding pocket analyses of the vaccine construct to TLR3 and TLR7 indicate high translation efficiency. Immune simulations demonstrated successful induction of immune responses and generation of antigen-specific memory cells. In conclusion, this study introduces an mRNA vaccine construct as a potential disease control strategy against ASF for in vitro confirmation.http://dx.doi.org/10.1155/vmi/2638167
spellingShingle Ella Mae Joy S. Sira
Lauren Emily Fajardo
Edward C. Banico
Nyzar Mabeth O. Odchimar
Fredmoore L. Orosco
Design of a Multiepitope Pan-Proteomic mRNA Vaccine Construct Against African Swine Fever Virus: A Reverse Vaccinology Approach
Veterinary Medicine International
title Design of a Multiepitope Pan-Proteomic mRNA Vaccine Construct Against African Swine Fever Virus: A Reverse Vaccinology Approach
title_full Design of a Multiepitope Pan-Proteomic mRNA Vaccine Construct Against African Swine Fever Virus: A Reverse Vaccinology Approach
title_fullStr Design of a Multiepitope Pan-Proteomic mRNA Vaccine Construct Against African Swine Fever Virus: A Reverse Vaccinology Approach
title_full_unstemmed Design of a Multiepitope Pan-Proteomic mRNA Vaccine Construct Against African Swine Fever Virus: A Reverse Vaccinology Approach
title_short Design of a Multiepitope Pan-Proteomic mRNA Vaccine Construct Against African Swine Fever Virus: A Reverse Vaccinology Approach
title_sort design of a multiepitope pan proteomic mrna vaccine construct against african swine fever virus a reverse vaccinology approach
url http://dx.doi.org/10.1155/vmi/2638167
work_keys_str_mv AT ellamaejoyssira designofamultiepitopepanproteomicmrnavaccineconstructagainstafricanswinefevervirusareversevaccinologyapproach
AT laurenemilyfajardo designofamultiepitopepanproteomicmrnavaccineconstructagainstafricanswinefevervirusareversevaccinologyapproach
AT edwardcbanico designofamultiepitopepanproteomicmrnavaccineconstructagainstafricanswinefevervirusareversevaccinologyapproach
AT nyzarmabethoodchimar designofamultiepitopepanproteomicmrnavaccineconstructagainstafricanswinefevervirusareversevaccinologyapproach
AT fredmoorelorosco designofamultiepitopepanproteomicmrnavaccineconstructagainstafricanswinefevervirusareversevaccinologyapproach